These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Progression of Alzheimer's disease and effect of scFv-h3D6 immunotherapy in the 3xTg-AD mouse model: An in vivo longitudinal study using Magnetic Resonance Imaging and Spectroscopy. Güell-Bosch J, Lope-Piedrafita S, Esquerda-Canals G, Montoliu-Gaya L, Villegas S. NMR Biomed; 2020 May; 33(5):e4263. PubMed ID: 32067292 [Abstract] [Full Text] [Related]
6. Effects of an Aβ-antibody fragment on Aβ aggregation and astrocytic uptake are modulated by apolipoprotein E and J mimetic peptides. Montoliu-Gaya L, Mulder SD, Veerhuis R, Villegas S. PLoS One; 2017 May; 12(11):e0188191. PubMed ID: 29155887 [Abstract] [Full Text] [Related]
7. Aβ-oligomer uptake and the resulting inflammatory response in adult human astrocytes are precluded by an anti-Aβ single chain variable fragment in combination with an apoE mimetic peptide. Montoliu-Gaya L, Mulder SD, Herrebout MAC, Baayen JC, Villegas S, Veerhuis R. Mol Cell Neurosci; 2018 Jun; 89():49-59. PubMed ID: 29625180 [Abstract] [Full Text] [Related]
11. Toluidine blue O modifies hippocampal amyloid pathology in a transgenic mouse model of Alzheimer's disease. Yuksel M, Biberoglu K, Onder S, Akbulut KG, Tacal O. Biochimie; 2018 Mar; 146():105-112. PubMed ID: 29248542 [Abstract] [Full Text] [Related]
12. Active full-length DNA Aβ42 immunization in 3xTg-AD mice reduces not only amyloid deposition but also tau pathology. Rosenberg RN, Fu M, Lambracht-Washington D. Alzheimers Res Ther; 2018 Nov 20; 10(1):115. PubMed ID: 30454039 [Abstract] [Full Text] [Related]
13. Immunotherapy to improve cognition and reduce pathological species in an Alzheimer's disease mouse model. Herline K, Prelli F, Mehta P, MacMurray C, Goñi F, Wisniewski T. Alzheimers Res Ther; 2018 Jun 18; 10(1):54. PubMed ID: 29914551 [Abstract] [Full Text] [Related]
14. Ultrasound with microbubbles improves memory, ameliorates pathology and modulates hippocampal proteomic changes in a triple transgenic mouse model of Alzheimer's disease. Shen Y, Hua L, Yeh CK, Shen L, Ying M, Zhang Z, Liu G, Li S, Chen S, Chen X, Yang X. Theranostics; 2020 Jun 18; 10(25):11794-11819. PubMed ID: 33052247 [Abstract] [Full Text] [Related]
16. Ca2+-permeable TRPV1 pain receptor knockout rescues memory deficits and reduces amyloid-β and tau in a mouse model of Alzheimer's disease. Kim J, Lee S, Kim J, Ham S, Park JHY, Han S, Jung YK, Shim I, Han JS, Lee KW, Kim J. Hum Mol Genet; 2020 Jan 15; 29(2):228-237. PubMed ID: 31814000 [Abstract] [Full Text] [Related]
17. Towards the improvement in stability of an anti-Aβ single-chain variable fragment, scFv-h3D6, as a way to enhance its therapeutic potential. Montoliu-Gaya L, Murciano-Calles J, Martinez JC, Villegas S. Amyloid; 2017 Sep 15; 24(3):167-175. PubMed ID: 28699800 [Abstract] [Full Text] [Related]
18. Intraneuronal APP, not free Aβ peptides in 3xTg-AD mice: implications for tau versus Aβ-mediated Alzheimer neurodegeneration. Winton MJ, Lee EB, Sun E, Wong MM, Leight S, Zhang B, Trojanowski JQ, Lee VM. J Neurosci; 2011 May 25; 31(21):7691-9. PubMed ID: 21613482 [Abstract] [Full Text] [Related]
19. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline. Clausen A, Xu X, Bi X, Baudry M. J Alzheimers Dis; 2012 May 25; 30(1):183-208. PubMed ID: 22406441 [Abstract] [Full Text] [Related]
20. Tetrahydrobiopterin Improves Recognition Memory in the Triple-Transgenic Mouse Model of Alzheimer's Disease, Without Altering Amyloid-β and Tau Pathologies. Fanet H, Tournissac M, Leclerc M, Caron V, Tremblay C, Vancassel S, Calon F. J Alzheimers Dis; 2021 May 25; 79(2):709-727. PubMed ID: 33337360 [Abstract] [Full Text] [Related] Page: [Next] [New Search]